Ubrelvy and Abdominal distension - a phase IV clinical study of FDA data

Summary:

Abdominal distension is reported as a side effect among people who take Ubrelvy (ubrogepant), especially for people who are female, 40-49 old, also take Fish Oil, and have Migraine.

The phase IV clinical study analyzes which people have Abdominal distension when taking Ubrelvy. It is created by eHealthMe based on reports of 3,537 people who have side effects when taking Ubrelvy from the FDA, and is updated regularly.

What is Ubrelvy?

Ubrelvy has active ingredients of ubrogepant. eHealthMe is studying from 3,585 Ubrelvy users. Check the latest studies of Ubrelvy.

What is Abdominal distension?

Abdominal distension is found to be associated with 2,554 drugs and 3,658 conditions by eHealthMe. Check the latest studies of Abdominal distension.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

3,537 people reported to have side effects when taking Ubrelvy.
Among them, 17 people (0.48%) have Abdominal distension.

Could Ubrelvy cause Abdominal distension?

Among these 17 people:

What is the gender of people who have Abdominal distension when taking Ubrelvy? *

female: 100 %
male: 0.0 %

What is the age of people who have Abdominal distension when taking Ubrelvy? *

What are other drugs people take besides Ubrelvy? *

Acetaminophen: 6 people, 35.29%
Aspirin: 6 people, 35.29%
Pregabalin: 6 people, 35.29%
Nurtec Odt: 6 people, 35.29%
Calcium: 6 people, 35.29%
Duloxetine Hydrochloride: 6 people, 35.29%
Botox: 6 people, 35.29%
Epinephrine: 6 people, 35.29%
Magnesium: 6 people, 35.29%
Fish Oil: 6 people, 35.29%

What are other side effects people have besides Abdominal distension? *

Nausea (feeling of having an urge to vomit): 7 people, 41.18%
Migraine (headache): 6 people, 35.29%
Sinusitis (inflammation of sinus): 6 people, 35.29%
Stomach Mass: 5 people, 29.41%
Infusion Site Mass: 5 people, 29.41%
Injection Site Mass: 5 people, 29.41%
Fever: 5 people, 29.41%
Lower Respiratory Tract Infection: 5 people, 29.41%
Respiratory Tract Infection: 5 people, 29.41%
Chronic Kidney Disease: 5 people, 29.41%

What are the existing conditions these people have? *

Migraine (headache): 8 people, 47.06%
Infection: 2 people, 11.76%
Nausea And Vomiting: 1 person, 5.88%
Nausea (feeling of having an urge to vomit): 1 person, 5.88%
Irritable Bowel Syndrome: 1 person, 5.88%
Immunodeficiency Common Variable: 1 person, 5.88%
Asthma: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Ubrelvy and have Abdominal distension?

- Check whether Abdominal distension is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ubrelvy:

Ubrelvy (3,585 reports)

Browse all side effects of Ubrelvy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abdominal distension:

Abdominal distension (2,554 drugs)

Browse all the conditions that are associated with Abdominal distension:

Abdominal distension (3,658 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ubrogepant (the active ingredients of Ubrelvy) and Ubrelvy (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.